Sign in
SCLN Stock Price, Chart, Stats & News
SciClone Pharmaceuticals, Inc.
Save
SciClone Pharmaceuticals, Inc. (SCLN) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
SCLN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 85.70% |
Operating margin | 20.76% |
Pretax margin | 21.32% |
Net margin | 19.19% |
Effective tax rate | 9.97% |
ROA | 12.70% |
ROE | 15.56% |
D/E | – |
Interest coverage ratio | – |
SCLN valuation
P/E | – |
P/S | – |
P/B | 2.60x |
P/CF | 16.22x |
P/FCF | – |
P/OCF | 16.22x |
PEG | 0.18x |
EV multiple | 3.83x |
About
SciClone Pharmaceuticals, Inc. operates as an international biopharmaceutical firm, concentrating its efforts on acquiring, advancing, and bringing to market therapeutic agents.
Similar securities
Based on sector and market capitalization
Report issue